Clinical Trial Update: Oral Colchicine in Men With Castrate Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating oral colchicine in men with castration-resistant prostate cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Prostate Cancer | Phase 2 | Status: WITHDRAWN